StitchR technology delivers large genes for muscular dystrophy treatment

Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is a big problem: size.

Could heparin offer new hope in the fight against dementia?

Heparin therapy delays Alzheimer’s diagnosis by one to two years, offering potential insights into new protective treatments. Large-scale health records show a promising association between

October 10, 2024

A dilemma in ALS, the first MASH drug, & why gene therapy is hard

What happens when an approved drug doesn’t work? Why don’t patients want gene therapy? And is MASH still a big deal? We cover all that

March 14, 2024

Study sheds light on the crucial role of glutamate tRNA fragments in brain aging and Alzheimer’s disease

A significant research paper published in the journal Cell Metabolism by the team of Prof. LIU Qiang at the University of Science and Technology of

May 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.